Machine signal
Active cluster sell — 6 distinct insiders, $1.1M, window ends Oct 7, 2026.
Figures computed from official regulatory filings — .
Analysttarget 48.88 USD (+71%) · consensus 4.41/5 · 13 buy · 4 hold · 0 sell
Ownershipinsiders 56.02% · institutions 54.64% · short 18.7% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Immunovant, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
Market information source · Oct 19, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 19, 2026
Open-market timeline · full history
36 buys257 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Stout Jay S | Sell | $51.2K | SEC | ||
| Gloria Melanie |
| Sell |
| $71.8K |
| SEC |
| Stout Jay S | Sell | $70.9K | SEC |
| Van Tuyl Christopher | Sell | $42.5K | SEC |
| Venker Eric | Other | $2.9M | SEC |
| Venker Eric | Exercise | $1.3M | SEC |
| Venker Eric | Sell | $119.6K | SEC |
| Venker Eric | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Van Tuyl Christopher | Sell | $103.5K | SEC |
| Pande Atultrack record | Sell | $64.9K | SEC |
| Pande Atultrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Pande Atultrack record | Exercise | $12.6K | SEC |
| Gloria Melanie | Sell | $135K | SEC |
| Pande Atultrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Pande Atultrack record | Sell | $59.7K | Unusual size | SEC |
| Girao Tiago | Sell | $263K | SEC |
| Stout Jay S | Sell | $110.5K | SEC |
| Pande Atultrack record | Exercise | $12.6K | SEC |
| Stout Jay S | Sell | $55.3K | SEC |
| Stout Jay S | Sell | $3.1K | SEC |
| Van Tuyl Christopher | Sell | $45.2K | SEC |
| Gloria Melanie | Sell | $76.3K | SEC |
| Van Tuyl Christopher | Sell | $2.5K | SEC |
| Gloria Melanie | Sell | $4.2K | SEC |
| Stout Jay S | Sell | $4.2K | SEC |